Altruist Biologics secures NMPA license, expanding its Hangzhou facility to solidify its role in China's rapidly growing ...

Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

Neuland Laboratories appoints Saharsh Davuluri as CEO to lead its $30m peptide facility expansion, targeting growth in ...

Despite persistent cost concerns, continued innovation is reinforcing the chromatography resin market’s long-term growth.

Leaders from around the industry discuss areas that stakeholders can explore to lower costs and improve accessibility.

Amid growing financial concerns and US vaccine hesitancy, the German company will close its mRNA site in Southeast Asia.

ABK Biomedical is building a Missouri facility to produce Eye90 microspheres, advancing radiopharmaceuticals for liver cancer ...

President Trump enacts tariffs on imported drugs to strengthen US manufacturing, sparking industry concerns over costs, ...